Related Experiment Video
Updated: Jun 21, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cardiovascular disease on hemodialysis: predictors of atherosclerosis and survival
Ahmed Balsam1, Mohsen M El Kossi, Robert Lord
1Sheffield Kidney Institute, Northern General Hospital, Sheffield, UK.
Insights
Cardiovascular disease is a major risk for hemodialysis patients. Atherosclerosis, indicated by high carotid intima-media thickness (IMT), inflammation, and homocysteine, significantly increases mortality risk in these patients.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Cardiovascular disease (CVD) is the primary cause of death in hemodialysis (HD) patients, exceeding traditional risk factors.
- Atherosclerosis, a key contributor to CVD, requires further investigation in HD populations.
Purpose of the Study:
- To identify factors influencing atherosclerosis, measured by carotid artery intima-media thickness (IMT).
- To assess the impact of IMT and associated markers on cardiovascular mortality in HD patients.
Main Methods:
- A cohort of 50 new HD patients was studied.
- Baseline assessments included carotid artery IMT, atheromatous plaques, plasma homocysteine (Hcy), C-reactive protein (CRP), and other biochemical markers.
- Patients were followed for 2 years, with mortality analyzed using survival analysis and Cox proportional hazards models.
Main Results:
- 40% of patients had IMT > 0.8 mm at baseline, associated with older age, higher CRP, and lower albumin.
- Increased IMT was linked to higher calcium and CRP levels.
- During 2-year follow-up, 30% of patients died, primarily from CVD. High IMT, Index of Coexistent Disease, and Hcy were significant predictors of mortality.
Conclusions:
- Inflammation markers and elevated serum calcium predict increased carotid artery IMT in HD patients.
- High IMT, comorbidity index, and plasma Hcy are associated with increased all-cause mortality risk in this cohort.
Abstract:
Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD) patients. This could not be explained by the known traditional CVD risk factors. In this study, we attempted to elucidate the factors influencing atherosclerosis, as measured by carotid artery intima-media thickness (IMT), in HD patients and their impact on cardiovascular mortality. A cohort of 50 patients started on HD was selected for this study. At baseline, IMT and the presence of atheromatous plaques were assessed. Plasma homocysteine (Hcy), malondialdehyde, total antioxidant capacity, von Willebrand factor, vitamins C, E, B(6), B(12), folate, and C-reactive protein (CRP) were also measured. Patients were followed up for 2 years to determine the impact of IMT and associated markers on mortality using survival analysis as well as Cox proportional hazard. At baseline, 40% of the patients had IMT>0.8 mm. They were older, had higher CRP (P<0.001), and lower serum albumin (P=0.03). Intima-media thickness >0.8 mm was associated with high calcium (risk ratio [RR]: 6.06; confidence interval [CI]: 0.75-12.25) and CRP (RR: 10.94 [CI: 2.56-46.74]). Fifteen patients (30%) died during the 2-year follow-up; the main cause of death was CVD (42%). The relative risk mortality was high with increased IMT (RR: 120.04 [CI: 4.18-3445.9]), Index of Coexistent Disease for CVD (RR: 4.04 [CI: 1.92-8.5]), and plasma Hcy (RR: 1.08 [CI: 1.02-1.13]). Markers of inflammation and increased serum calcium were significant predictors of increased carotid artery IMT. High IMT, Index of Coexistent Disease, and Hcy were associated with a high RR of all-cause mortality among a cohort of HD patients.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Hemodialysis I: Introduction
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Chronic Kidney Disease II: Clinical Manifestations
